Log in  First Connection?

Kidney TransplantationArchives

Health-related quality of life in Chinese kidney transplant recipients assessed by Chinese medicine quality of life-11 dimensions (CQ-11D)

 Published on 17/06/2026 |  Original article (Full-text)  | Guo, Shaobo et al. | Health and Quality of Life Outcomes. Volume 24(1).

Health-related quality of life (HRQoL) in kidney transplant recipients (KTRs) is a key concern influenced by physiological, social, and cultural factors. However, yet commonly used assessment tools in previous studies do not adequately capture the unique sociocultural context of Chinese populations....

Kidney disease after hematopoietic stem cell transplant-treatment standard

 Published on 10/06/2026 |  Original article (Full-text)  | Yu Zhang et al. | Nephrology Dialysis Transplantation. Volume 40(12).

Hematopoietic stem cell transplant (HSCT) is a well-established procedure for malignant and nonmalignant conditions. Despite its therapeutic benefits, kidney disease remains a common complication that significantly affects patient outcomes. Kidney injury post-HSCT manifests as acute kidney injury and...

KT-LLM: an evidence-grounded and sequence text framework for auditable kidney transplant modeling

 Published on 03/06/2026 |  Original article (Full-text)  | Zheng Haofeng et al. | npj Digital Medicine 2026; 9(1): 142

In real-world management and research of kidney transplantation(KT), critical evidence has long evolved along two parallel tracks: structured longitudinal follow-up and text-defined rules. On the one hand, OPTN and SRTR collect Transplant Recipient Follow-up (TRF) at 6 months post transplant, at 1 year,...

Regulatory T cells in kidney transplantation: mechanisms, therapeutic advances, and future directions

 Published on 27/05/2026 |  Original article (Full-text)  | Yunting Shao et al. | Immunotherapy 2026; 18(5-6): 479-501

Regulatory T cells (Tregs) play a pivotal role as key modulators of immune tolerance in kidney transplantation, a critical therapeutic approach for end-stage renal disease. Despite advances in surgical techniques and immunosuppressive regimens, kidney transplantation continues to face significant challenges,...

Peri-kidney transplant management in autosomal dominant hypocalcaemia type 1

 Published on 20/05/2026 |  Original article (Full-text)  | Alice Glaysher   et al. | Pediatric Nephrology 2026; 41(7): 2021-4

Autosomal dominant hypocalcaemia (ADH) is a rare abnormality of calcium homeostasis. It is usually associated with gain-of-function mutations in the calcium sensing receptor (CaSR, ADH1) or its associated G-protein (GNA11, autosomal dominant hypocalcaemia type 2 [ADH2]). The CaSR is expressed in several...